Form 4 for TMDX TransMedics Group, Inc.
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0000899243-23-003882 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-03 | 2023-02-01 | TMDX | Gordon Stephen | CFO | M - OptEx | $16.14 | +5,000 | 10.7K | +88% | +$80.7K |
| D | 2023-02-03 | 2023-02-01 | TMDX | Gordon Stephen | CFO | S - Sale+OE | $62.64 | -5,000 | 5,714 | -47% | -$313.2K |
| D | 2023-02-03 | 2023-02-01 | TMDX | Gordon Stephen | CFO | M - OptEx | $0.00 | -5,000 | 20.7K | -19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | M | A | 5,000 | $16.14 | 10,714 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-01 | S | D | 5,000 | $62.64 | 5,714 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-02-01 | M | D | 5,000 | $0.00 | 20,728 | D | $16.14 · — to 2030-02-27 | 5,000 Common Stock | (F2) The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024. |